Metabolic-Fit / 100
Vaylen review
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Prices and terms come from the company's own published pages. This is background reading, not medical advice.
Semaglutide: From $83.25/mo on a 12-month prepaid program; tirzepatide: From $149/mo on a 12-month prepaid program. These are monthly equivalents of 12-month programs billed upfront; a current single-month standard rate is not published.
From $83.25/mo on a 12-month prepaid program
- Confirm HSA / FSA coverage
- Public signup path reviewed
- Confirm your total cost
Vaylen at a glance
- Semaglutide
- From $83.25/mo on a 12-month prepaid program
- Tirzepatide
- From $149/mo on a 12-month prepaid program
- Coverage
- Nationwide
- Brand-name
- Yes
How we scored Vaylen
Every factor comes from Vaylen's own published pricing, disclosures and oversight, and the six combine into the 49/100 Metabolic-Fit Score on our weighted six-factor framework. Commissions don't change a provider's score.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Oversight and lab support fall short of the best on our list — the review below says exactly where.
Cost is unpredictable or sits at the premium end.
Support is thin once the prescription ships.
Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.
How we checked this review
Semaglutide: From $83.25/mo on a 12-month prepaid program; tirzepatide: From $149/mo on a 12-month prepaid program. These are monthly equivalents of 12-month programs billed upfront; a current single-month standard rate is not published.
What to expect when you sign up
We walked Vaylen's public signup — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1The homepage lists five real price points directly — compounded semaglutide, compounded tirzepatide, a compounded oral tablet, plus brand Ozempic and Zepbound — no intake required to see a number
- 2HIPAA-secure intake described as 'clinician-directed' GLP-1 care
- 3Site states clear, transparent pricing with no insurance required and no hidden costs
What we noticed
- One of the more complete public pricing pages — both compounded and brand options for both molecules are itemized without starting an intake
- The oral tablet tier ('$259/mo') isn't clearly split by molecule on the pricing page — treated conservatively as a semaglutide row here
- No mention anywhere of pregnancy, breastfeeding, postpartum care, or PCOS
Pricing
| Medication | Price | Plan |
|---|---|---|
| Compounded semaglutide | $83.25 | 12-month prepaid programHomepage monthly equivalent; billed upfront, shorter plans available but not currently itemized. |
| Compounded tirzepatide | $149 | 12-month prepaid programBilled upfront; not monthly payment. |
| Oral semaglutide | $99 | 12-month prepaid oral programBilled upfront; not monthly payment. |
Swipe the table to see plan details →
Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what Vaylen's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.
What we like
- Genuinely offers FDA-approved brand Ozempic and Zepbound alongside compounded options, not just one or the other
- Compounded oral (needle-free) tablet option available
- Semaglutide: From $83.25/mo on a 12-month prepaid program; tirzepatide: From $149/mo on a 12-month prepaid program.
The caveats
- No mention anywhere of pregnancy, breastfeeding, postpartum care, or PCOS
- No named compounding pharmacy or medical director found on the site
- These are monthly equivalents of 12-month programs billed upfront; a current single-month standard rate is not published.
The low equivalents require a year paid upfront
Vaylen advertises compounded semaglutide injections from $83.25 a month and tirzepatide injections from $149, each explicitly tied to a twelve-month program billed upfront. Oral semaglutide starts from $99 on the same annual basis. Those are commitment-based equivalents, not confirmed prices for trying one month and deciding later whether to continue. A prospective patient should request the full amount due, exact supply and renewal arrangement before comparing the headline with a flexible monthly program elsewhere.
A separate first-month-from-$99 banner should not be combined with the annual equivalents to create an offer the company has not clearly described. Ask which product qualifies, how the opening amount is collected and what is owed afterward. No current single-month standard rate is established in the public information. That gap matters to someone uncertain about the service or expecting a possible change in care, because the cheapest published average does not reveal the cost of retaining flexibility or stopping during a longer purchased term.
Oral, injectable and brand routes answer different preferences
The oral semaglutide option may interest someone reluctant to inject, but it is a distinct compounded preparation. It should not be assumed to share an approved tablet's labeling, evidence or administration instructions. The clinician needs to identify the actual formulation and explain the choice, while the financial quote should attach the correct supply and commitment to that same product. A matching ingredient name does not make a compounded tablet interchangeable with an injection or guarantee that an annual purchase is clinically suitable throughout its term.
Vaylen also describes FDA-approved brand access, including Ozempic and Zepbound. Those routes need separate current product-and-dose quotes rather than inherit the lower compounded amounts. Ask whether the branded payment includes care, which pharmacy supplies the product and what conditions affect its charge. A broad menu can support a useful prescribing discussion, but the smallest number in one category should not become the price of another. Someone already using a brand should establish continuity with the clinician rather than infer it from a logo or product name on the storefront.
A long purchase should follow a clear care agreement
The service describes nationwide availability, while no complete state list, named medical director or compounding pharmacy is established in the available material. Confirm the actual consultation location, delivery address, assigned practice and dispenser before choosing a year-long program. Those identities are useful when a prescription changes, a shipment raises a concern or a billing question needs a responsible contact. An annual price alone does not explain how medical questions are handled between deliveries or whether live follow-up is available when needed.
The public information also does not provide a developed postpartum, breastfeeding or PCOS pathway. Relevant history and coordination with existing care require direct discussion. Obtain cancellation deadlines, refund limits and the treatment of unshipped supply before paying upfront. Vaylen is most relevant when a specific offered formulation fits a clinician-supported plan and the full annual commitment is acceptable. Its current prices can help compare long-term offers, but they should not stand in for an unpriced flexible option, an identifiable clinical relationship or clear rules for a treatment course that changes.
The bottom line for mothers
Best for: Someone comfortable with the stated plan commitment who confirms the full prescribed treatment cost before paying.
Alternatives to Vaylen
These are partners — we may be paid if you sign up through these links. The full list has every provider we cover, partner or not.
- Visit CoreAge Rx86
Metabolic-Fit / 100
CoreAge RxFeatured partnerCoreAge's officially linked public offer advertises compounded semaglutide at $79/month and tirzepatide at $129/month across doses, with care and overnight shipping included. It describes one-time purchases without a required subscription. Main navigation still shows semaglutide from $99; confirm your prescription quantity and total, and read the refund limits before paying.
- Visit Gala Health84
Metabolic-Fit / 100
Semaglutide from $129 and tirzepatide from $179 a month, all doses included — a reasonable option if you can live with a yearly plan, a month-to-month price you only see at checkout, and a pharmacy it doesn't name.
- Visit Wellmedr46
Metabolic-Fit / 100
One of very few programs that prices the brand-name medications — Ozempic at $1,399, Zepbound at $1,599 — wrapped around a compounded offer that's much harder to pin down.
Providers like Vaylen
Keep comparing Vaylen
Head-to-head & alternatives
Ranked boards
- Best GLP-1 for women
- Best GLP-1 for PCOS & insulin resistance
- Best GLP-1 for perimenopause
- Best GLP-1 while breastfeeding (safety-first)
- Cheapest GLP-1 programs
- Compounded tirzepatide providers
- Cheapest tirzepatide online
- Cheapest semaglutide online
- Where to get Zepbound online
- Semaglutide vs tirzepatide: which is right for you
Related reading for mothers
Vaylen, answered
- How much does Vaylen cost?
- Vaylen does not establish a comparable recurring monthly medication rate. Published pricing: From $83.25/mo on a 12-month prepaid program for semaglutide; From $149/mo on a 12-month prepaid program for tirzepatide. Ask for the complete charge, supply period and renewal terms before committing.
- Is Vaylen safe to use while breastfeeding?
- Pregnancy is the clear line: no GLP-1 is established as safe while you are pregnant. For breastfeeding, the Wegovy injection, Ozempic, Zepbound and Mounjaro labels report little or no data on the drug in breast milk and ask you and your clinician to weigh the benefits of breastfeeding against your need for the medicine. Compounded versions carry no label of their own, so that conversation matters more, not less. Vaylen is not an exception to any of that — settle the timing with your own clinician.
- Does Vaylen offer both semaglutide and tirzepatide?
- Yes — Vaylen offers both molecules. Tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, which matters for PCOS and after gestational diabetes.
- How does Vaylen score for mothers?
- Vaylen scores 49/100 on our Metabolic-Fit Score, a weighted read of six things mothers actually have to care about. CoreAge Rx, a featured partner, is worth a side-by-side look.
Pricing, states and verification reflect Vaylen's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.